Literature DB >> 3468857

Kinetics of amino acid transport at the blood-brain barrier studied using an in situ brain perfusion technique.

Q R Smith, Y Takasato.   

Abstract

The in situ brain perfusion technique of Takasato et al. allows accurate measurements of regional amino-acid influx across the blood-brain barrier. Influx can be determined in the absence of competing amino acids, using saline perfusate, or in the presence of physiological concentrations of amino acids, using plasma or blood perfusate. The concentration dependence of cerebrovascular LNAA transport is best described by a model with a Michaelis-Menten saturable and a nonsaturable component. Vmax values for four LNAAs are similar and average 10 X 10(-4) mumol X sec-1 X g-1. In contrast, Km values differ by up to 10-fold with the lowest value for leucine. Competitive inhibition increases the apparent Km for transport from plasma by approximately 20-fold. These data provide accurate new estimates of the kinetic constants that describe amino-acid transport across the blood-brain barrier. In addition, they indicate that the cerebrovascular transport capacity (Vmax) and affinity (1/Km) are greater than previously reported with the brain uptake index technique.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3468857     DOI: 10.1111/j.1749-6632.1986.tb27150.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  23 in total

1.  In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles.

Authors:  Paul R Lockman; Joanna Koziara; Karen E Roder; Jennifer Paulson; Thomas J Abbruscato; Russell J Mumper; David D Allen
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

Review 2.  How to measure drug transport across the blood-brain barrier.

Authors:  Ulrich Bickel
Journal:  NeuroRx       Date:  2005-01

3.  Coadministration of branched-chain amino acids and lipopolysaccharide causes matrix metalloproteinase activation and blood-brain barrier breakdown.

Authors:  Giselli Scaini; Meline O S Morais; Leticia S Galant; Francieli Vuolo; Dhébora M Dall'Igna; Matheus A B Pasquali; Vitor M Ramos; Daniel P Gelain; Jose Claudio F Moreira; Patrícia F Schuck; Gustavo C Ferreira; Francisco G Soriano; Felipe Dal-Pizzol; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2014-01-05       Impact factor: 5.590

Review 4.  Peptides at the blood brain barrier: Knowing me knowing you.

Authors:  Thomas P Davis; Thomas J Abbruscato; Richard D Egleton
Journal:  Peptides       Date:  2015-04-30       Impact factor: 3.750

Review 5.  ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.

Authors:  Young Hee Choi; Ai-Ming Yu
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 6.  Anatomy and physiology of the blood-brain barrier.

Authors:  Yonatan Serlin; Ilan Shelef; Boris Knyazer; Alon Friedman
Journal:  Semin Cell Dev Biol       Date:  2015-02-11       Impact factor: 7.727

7.  Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat.

Authors:  N H Greig; T T Soncrant; H U Shetty; S Momma; Q R Smith; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

8.  Contributions of biological tumor parameters to the incorporation rate of L: -[methyl-(11)C] methionine into astrocytomas and oligodendrogliomas.

Authors:  Takeko Nojiri; Tadashi Nariai; Masaru Aoyagi; Michio Senda; Kenji Ishii; Kiichi Ishiwata; Kikuo Ohno
Journal:  J Neurooncol       Date:  2008-12-20       Impact factor: 4.130

9.  Quantitative fluorescence microscopy provides high resolution imaging of passive diffusion and P-gp mediated efflux at the in vivo blood-brain barrier.

Authors:  Rajendar K Mittapalli; Vamshi K Manda; Kaci A Bohn; Chris E Adkins; Paul R Lockman
Journal:  J Neurosci Methods       Date:  2013-08-02       Impact factor: 2.390

10.  Classical maple syrup urine disease and brain development: principles of management and formula design.

Authors:  Kevin A Strauss; Bridget Wardley; Donna Robinson; Christine Hendrickson; Nicholas L Rider; Erik G Puffenberger; Diana Shellmer; Diana Shelmer; Ann B Moser; D Holmes Morton
Journal:  Mol Genet Metab       Date:  2010-01-12       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.